Carclo (C1Y) Stock Overview
Provides plastic components for the life sciences, aerospace, and advanced industries in the United Kingdom, France, the Czech Republic, China, India, rest of Europe, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
C1Y Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Carclo plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.65 |
| 52 Week High | UK£0.90 |
| 52 Week Low | UK£0.23 |
| Beta | 0.72 |
| 1 Month Change | 12.07% |
| 3 Month Change | -15.03% |
| 1 Year Change | 150.00% |
| 3 Year Change | 450.85% |
| 5 Year Change | 236.79% |
| Change since IPO | -44.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| C1Y | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 0.8% | 1.5% | 2.1% |
| 1Y | 150.0% | -2.7% | 17.6% |
Return vs Industry: C1Y exceeded the German Chemicals industry which returned -2.6% over the past year.
Return vs Market: C1Y exceeded the German Market which returned 17.2% over the past year.
Price Volatility
| C1Y volatility | |
|---|---|
| C1Y Average Weekly Movement | 9.6% |
| Chemicals Industry Average Movement | 3.6% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in DE Market | 12.6% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: C1Y's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: C1Y's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1924 | 958 | Frank Doorenbosch | www.carclo.co.uk |
Carclo plc, together with its subsidiaries, provides plastic components for the life sciences, aerospace, and advanced industries in the United Kingdom, France, the Czech Republic, China, India, rest of Europe, North America, and internationally. It operates through two segments, CTP and Speciality. The company offers in vitro diagnostics and medical devices, including microfluidic, pipettes, cuvettes, multiwells, and capillary blood sampling devices; drug delivery products comprising inhaler systems and auto injector pens; and injection moulded components for ATM cash storage and dispensing systems, lighting control, and electronics and megatronics.
Carclo plc Fundamentals Summary
| C1Y fundamental statistics | |
|---|---|
| Market cap | €48.63m |
| Earnings (TTM) | €2.18m |
| Revenue (TTM) | €135.60m |
Is C1Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| C1Y income statement (TTM) | |
|---|---|
| Revenue | UK£117.50m |
| Cost of Revenue | UK£47.68m |
| Gross Profit | UK£69.82m |
| Other Expenses | UK£67.93m |
| Earnings | UK£1.89m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.026 |
| Gross Margin | 59.42% |
| Net Profit Margin | 1.61% |
| Debt/Equity Ratio | -281.2% |
How did C1Y perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/12 06:54 |
| End of Day Share Price | 2026/01/12 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Carclo plc is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andrew Smith | Panmure Liberum |
| Henry Carver | Peel Hunt LLP |
| Jonathan Lienard | Singer Capital Markets |